Skip to main content
Top
Published in: Arthritis Research & Therapy 2/2001

01-11-2001 | Commentary

Staphylococcus aureus and Wegener's granulomatosis

Authors: Eliane R Popa, Coen A Stegeman, Cees GM Kallenberg, Jan Willem Cohen Tervaert

Published in: Arthritis Research & Therapy | Issue 2/2001

Login to get access

Abstract

Wegener's granulomatosis (WG) is a form of systemic vasculitis. It is characterized by granulomatous inflammation in the upper and lower airways, vasculitis and necrotizing glomerulonephritis, and is strongly associated with antineutrophil cytoplasmic antibodies against proteinase 3. Since the etiology of the disease is not clear, treatment, consisting of corticosteroids and immunosuppressives, is nonspecific and associated with severe side effects. Pinpointing the trigger(s) of the disease would highly improve treatment. Clinical evidence shows that an infectious agent, the bacterium Staphylococcus aureus, is a risk factor for disease relapse, suggesting its involvement in the pathogenesis of WG. Here we review both clinical and experimental data that either indicate or support a role for S. aureus in WG.
Literature
1.
go back to reference van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, van der Giessen M, van der Hem GK, The TH: Autoantibodies to neutrophils and monocytes: a new tool for diagnosis and a marker of disease activity in Wegener's gran-ulomatosis. Lancet. 1985, i: 425-429. 10.1016/S0140-6736(85)91147-X.CrossRef van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, van der Giessen M, van der Hem GK, The TH: Autoantibodies to neutrophils and monocytes: a new tool for diagnosis and a marker of disease activity in Wegener's gran-ulomatosis. Lancet. 1985, i: 425-429. 10.1016/S0140-6736(85)91147-X.CrossRef
2.
go back to reference Cohen Tervaert JW, van der Woude FJ, Fauci AS, Ambrus JL, Velosa J, Keane WF, Meijer S, van der Giessen M, The TH, van der Hem GK, Kallenberg CGM: Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Int Med. 1989, 149: 2461-2465. 10.1001/archinte.149.11.2461.CrossRef Cohen Tervaert JW, van der Woude FJ, Fauci AS, Ambrus JL, Velosa J, Keane WF, Meijer S, van der Giessen M, The TH, van der Hem GK, Kallenberg CGM: Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Int Med. 1989, 149: 2461-2465. 10.1001/archinte.149.11.2461.CrossRef
3.
go back to reference Falk RJ, Jennette JC: Anti-neutrophil cytoplasmic autoantibod-ies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med. 1988, 318: 1651-1657.PubMedCrossRef Falk RJ, Jennette JC: Anti-neutrophil cytoplasmic autoantibod-ies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med. 1988, 318: 1651-1657.PubMedCrossRef
4.
go back to reference Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW: Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential. Kidney Int. 1994, 46: 1-15.PubMedCrossRef Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW: Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential. Kidney Int. 1994, 46: 1-15.PubMedCrossRef
5.
go back to reference Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, McCluskey RT, Sinico AR, Rees AJ, van Es LA, Waldherr R, Wiika A: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994, 37: 187-192.PubMedCrossRef Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, McCluskey RT, Sinico AR, Rees AJ, van Es LA, Waldherr R, Wiika A: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994, 37: 187-192.PubMedCrossRef
6.
go back to reference Fauci AS, Haynes BF, Katz P, Wolff SM: Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983, 98: 76-85.PubMedCrossRef Fauci AS, Haynes BF, Katz P, Wolff SM: Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983, 98: 76-85.PubMedCrossRef
7.
go back to reference Pinching AJ, Rees AJ, Pussell BA, Lockwood CM, Mitchison RS, Peters DK: Relapses in Wegener's granulomatosis: the role of infection. Br Med J. 1980, 281: 836-838.PubMedPubMedCentralCrossRef Pinching AJ, Rees AJ, Pussell BA, Lockwood CM, Mitchison RS, Peters DK: Relapses in Wegener's granulomatosis: the role of infection. Br Med J. 1980, 281: 836-838.PubMedPubMedCentralCrossRef
8.
go back to reference DeRemee RA, McDonald TJ, Weiland LH: Wegener's granulomatosis:observations on treatment with antimicrobial agents. Mayo Clin Proc. 1985, 60: 27-32.PubMedCrossRef DeRemee RA, McDonald TJ, Weiland LH: Wegener's granulomatosis:observations on treatment with antimicrobial agents. Mayo Clin Proc. 1985, 60: 27-32.PubMedCrossRef
9.
go back to reference Stegeman CA, Cohen Tervaert JW, de Jong PE, Kallenberg CGM: Trimethoprim-sulfamethoxazole for the prevention of relapses of Wegener's granulomatosis. New Engl J Med. 1996, 335: 16-20. 10.1056/NEJM199607043350103.PubMedCrossRef Stegeman CA, Cohen Tervaert JW, de Jong PE, Kallenberg CGM: Trimethoprim-sulfamethoxazole for the prevention of relapses of Wegener's granulomatosis. New Engl J Med. 1996, 335: 16-20. 10.1056/NEJM199607043350103.PubMedCrossRef
10.
go back to reference Roberts DE, Curd JG: Sulfonamides as anti-inflammatory agents in the treatment of Wegener's granulomatosis. Arthritis Rheum. 1990, 33: 1590-1593.PubMedCrossRef Roberts DE, Curd JG: Sulfonamides as anti-inflammatory agents in the treatment of Wegener's granulomatosis. Arthritis Rheum. 1990, 33: 1590-1593.PubMedCrossRef
11.
go back to reference Stegeman CA, Cohen Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CGM: Association of chronic nasal carriage of S. aureus and higher relapse rates in Wegener's granulomatosis. Ann Int Med. 1994, 120: 12-17.PubMedCrossRef Stegeman CA, Cohen Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CGM: Association of chronic nasal carriage of S. aureus and higher relapse rates in Wegener's granulomatosis. Ann Int Med. 1994, 120: 12-17.PubMedCrossRef
12.
go back to reference McCormick JK, Yarwood JM, Schlievert PM: Toxic shock syndrome and bacterial superantigens: An update. Annu Rev Microbiol. 2001, 55: 77-104. 10.1146/annurev.micro.55.1.77.PubMedCrossRef McCormick JK, Yarwood JM, Schlievert PM: Toxic shock syndrome and bacterial superantigens: An update. Annu Rev Microbiol. 2001, 55: 77-104. 10.1146/annurev.micro.55.1.77.PubMedCrossRef
13.
go back to reference Marrack P, Kappler J: The staphylococcal enterotoxins and their relatives. Science. 1990, 248: 705-711.PubMedCrossRef Marrack P, Kappler J: The staphylococcal enterotoxins and their relatives. Science. 1990, 248: 705-711.PubMedCrossRef
14.
go back to reference Sasso EH, Silverman GJ, Mannik M: Human IgM molecules that bind staphylococcal protein A contain VHIII heavy chains. J Immunol. 1989, 142: 2778-2783.PubMed Sasso EH, Silverman GJ, Mannik M: Human IgM molecules that bind staphylococcal protein A contain VHIII heavy chains. J Immunol. 1989, 142: 2778-2783.PubMed
15.
go back to reference Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, Leung DY: Selective expansion of T-cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. Proc Natl Acad Sci USA. 1992, 89: 4966-4970. Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, Leung DY: Selective expansion of T-cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. Proc Natl Acad Sci USA. 1992, 89: 4966-4970.
16.
go back to reference Abe J, Kotzin BL, Messner C, Melish ME, Takahashi M, Fulton D, Romagne F, Malissen B, Leung DY: Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med. 1993, 177: 791-796.PubMedCrossRef Abe J, Kotzin BL, Messner C, Melish ME, Takahashi M, Fulton D, Romagne F, Malissen B, Leung DY: Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med. 1993, 177: 791-796.PubMedCrossRef
17.
go back to reference Leung DYM, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM: Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet. 1993, 342: 1385-1388. 10.1016/0140-6736(93)92752-F.PubMedCrossRef Leung DYM, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM: Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet. 1993, 342: 1385-1388. 10.1016/0140-6736(93)92752-F.PubMedCrossRef
18.
go back to reference Leung DYM, Sullivan KE, Brown-Whitehorn TF, Fehringer AP, Allen S, Finkel TH, Washington RL, Makida R, Schlievert PM: Association of toxic shock syndrome-secreting and exfoliative toxin-secreting Staphylococcus aureus with Kawasaki syndrome complicated by coronary artery disease. Pediatr Res. 1997, 42: 268-272.PubMedCrossRef Leung DYM, Sullivan KE, Brown-Whitehorn TF, Fehringer AP, Allen S, Finkel TH, Washington RL, Makida R, Schlievert PM: Association of toxic shock syndrome-secreting and exfoliative toxin-secreting Staphylococcus aureus with Kawasaki syndrome complicated by coronary artery disease. Pediatr Res. 1997, 42: 268-272.PubMedCrossRef
19.
go back to reference Giscombe R, Grunewald J, Nityanand S, Lefvert AK: T cell receptor (TCR) V gene usage in patients with systemic necrotizing vasculitis. Clin Exp Immunol. 1995, 101: 213-219.PubMedPubMedCentralCrossRef Giscombe R, Grunewald J, Nityanand S, Lefvert AK: T cell receptor (TCR) V gene usage in patients with systemic necrotizing vasculitis. Clin Exp Immunol. 1995, 101: 213-219.PubMedPubMedCentralCrossRef
20.
go back to reference Simpson IJ, Skinner MA, Geursen A, Peake JS, Abbott WG, Fraser JD, Lockwood CM, Tan PL: Peripheral blood T lymphocytes in systemic vasculitis: increased T cell receptor Vβ2 gene usage in microscopic polyarteritis. Clin Exp Immunol. 1995, 101: 220-226.PubMedPubMedCentralCrossRef Simpson IJ, Skinner MA, Geursen A, Peake JS, Abbott WG, Fraser JD, Lockwood CM, Tan PL: Peripheral blood T lymphocytes in systemic vasculitis: increased T cell receptor Vβ2 gene usage in microscopic polyarteritis. Clin Exp Immunol. 1995, 101: 220-226.PubMedPubMedCentralCrossRef
21.
go back to reference Sibilia J, Benlagha K, Vanhille P, Ronco P, Brouet JC, Mariette X: Structural analysis of human antibodies to proteinase 3 from patients with Wegener granulomatosis. J Immunol. 1997, 159: 712-719.PubMed Sibilia J, Benlagha K, Vanhille P, Ronco P, Brouet JC, Mariette X: Structural analysis of human antibodies to proteinase 3 from patients with Wegener granulomatosis. J Immunol. 1997, 159: 712-719.PubMed
22.
go back to reference Pertschuk L, Woda B, Vuletin J, Brigati DJ, Soriano CB, Nicastri AD: Glomerulonephritis due to Staphylococcus aureus antigen. Am J Clin Pathol. 1976, 65: 301-307.PubMed Pertschuk L, Woda B, Vuletin J, Brigati DJ, Soriano CB, Nicastri AD: Glomerulonephritis due to Staphylococcus aureus antigen. Am J Clin Pathol. 1976, 65: 301-307.PubMed
23.
go back to reference Sato M, Nakazoro H, Ofuji T: The pathogenic role of Staphylococcus aureus in primary human glomerulonephritis. Clin Nephrol. 1979, 11: 190-195.PubMed Sato M, Nakazoro H, Ofuji T: The pathogenic role of Staphylococcus aureus in primary human glomerulonephritis. Clin Nephrol. 1979, 11: 190-195.PubMed
24.
go back to reference Yousif Y, Schlitz E, Okada K, Batsford S, Vogt A: Staphylococcal neutral phosphatase. A highly cationic molecule with binding properties for immunoglobulin. APMIS. 1994, 102: 891-900.PubMedCrossRef Yousif Y, Schlitz E, Okada K, Batsford S, Vogt A: Staphylococcal neutral phosphatase. A highly cationic molecule with binding properties for immunoglobulin. APMIS. 1994, 102: 891-900.PubMedCrossRef
25.
go back to reference Yousif Y, Okada K, Batsford S, Vogt A: Induction of glomerulonephritis in rats with staphylococcal phosphatase: new aspects in post-infectious ICGN. Kidney Int. 1996, 50: 290-297.PubMedCrossRef Yousif Y, Okada K, Batsford S, Vogt A: Induction of glomerulonephritis in rats with staphylococcal phosphatase: new aspects in post-infectious ICGN. Kidney Int. 1996, 50: 290-297.PubMedCrossRef
26.
go back to reference Brons RH, Klok P, van Dijk N, Kallenberg CGM, Tiebosch A, Cohen Tervaert JW: Staphylococcal acid phosphatase induces severe crescentic glomerulonephritis in immunized Brown-Norway rats: relevance for Wegener's granulomatosis? [Abstract]. Clin Exp Immunol. 2000, 120: 44- Brons RH, Klok P, van Dijk N, Kallenberg CGM, Tiebosch A, Cohen Tervaert JW: Staphylococcal acid phosphatase induces severe crescentic glomerulonephritis in immunized Brown-Norway rats: relevance for Wegener's granulomatosis? [Abstract]. Clin Exp Immunol. 2000, 120: 44-
27.
go back to reference Brons RH, Bakker HI, van Wijk RT, van Dijk NW, Muller Kobold AC, Limburg PC, Manson WL, Kallenberg CG, Cohen Tervaert JW: Staphyloccal acid phosphatase binds to endothelial cells via charge interaction: a pathogenic role in Wegener's granulomatosis?. Clin Exp Immunol. 2000, 119: 566-573. 10.1046/j.1365-2249.2000.01172.x.PubMedPubMedCentralCrossRef Brons RH, Bakker HI, van Wijk RT, van Dijk NW, Muller Kobold AC, Limburg PC, Manson WL, Kallenberg CG, Cohen Tervaert JW: Staphyloccal acid phosphatase binds to endothelial cells via charge interaction: a pathogenic role in Wegener's granulomatosis?. Clin Exp Immunol. 2000, 119: 566-573. 10.1046/j.1365-2249.2000.01172.x.PubMedPubMedCentralCrossRef
28.
go back to reference Heeringa P, Brouwer E, Klok PA, Huitema MG, van den Born J, Weening JJ, Kallenberg CGM: Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat. Am J Pathol. 1996, 149: 1695-1706.PubMedPubMedCentral Heeringa P, Brouwer E, Klok PA, Huitema MG, van den Born J, Weening JJ, Kallenberg CGM: Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat. Am J Pathol. 1996, 149: 1695-1706.PubMedPubMedCentral
Metadata
Title
Staphylococcus aureus and Wegener's granulomatosis
Authors
Eliane R Popa
Coen A Stegeman
Cees GM Kallenberg
Jan Willem Cohen Tervaert
Publication date
01-11-2001
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 2/2001
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar392

Other articles of this Issue 2/2001

Arthritis Research & Therapy 2/2001 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.